Literature DB >> 1935502

Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.

I Koop1, S Dorn, H Koop, S Witzleb, C Beglinger, A Schafmayer, R Arnold.   

Abstract

The role of intraduodenal bile acids in the regulation of cholecystokinin (CCK), pancreatic polypeptide (PP), and secretin as well as exocrine pancreatic and biliary secretion was investigated by means of a duodenal marker perfusion technique in volunteers. The following solutions were perfused: (1) liquid test meal, (2) test meal with 6 g cholestyramine, (3) test meal with 2 g chenodeoxycholic acid (CDC), (4) test meal with 6 g cholestyramine and 2 g CDC, (5) 6 g cholestyramine alone, and (6) 2 g CDC alone. The test meal caused an immediate increase in CCK and PP plasma levels, whereas secretin was not significantly altered. CCK release was further enhanced by addition of cholestyramine, whereas CDC inhibited release. The stimulatory effect of cholestyramine was abolished by CDC. CDC alone and in combination with the test meal stimulated secretin release. The response of PP to the test meal was not altered by addition of either compound. Cholestyramine and CDC alone caused only a very small increase in CCK levels, whereas PP was stimulated to nearly postprandial values. Meal-stimulated pancreatic and biliary secretion was significantly enhanced by cholestyramine, CDC, and the combination of both. CDC and cholestyramine alone each stimulated enzyme and bile secretion to a greater extent than the test meal. We conclude that intraduodenal bile salts are a modulator of postprandial CCK release. Changes in exocrine pancreatic and biliary and PP secretion do not necessarily parallel CCK concentrations, suggesting that different mediators are involved in the observed bile acid-induced changes in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1935502     DOI: 10.1007/bf01296408

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Stimulation of pancreatic secretion by intraduodenal infusion of bile-salts.

Authors:  K G Wormsley
Journal:  Lancet       Date:  1970-09-19       Impact factor: 79.321

2.  Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats.

Authors:  G M Green; R L Lyman
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

3.  Exocrine pancreatic secretion and immunoreactive secretin (IRS) release after intraduodenal instillation of bile in man.

Authors:  M Osnes; L E Hanssen; O Flaten; J Myren
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

4.  Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex.

Authors:  C Owyang; D May; D S Louie
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

5.  Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide.

Authors:  T E Adrian; H S Besterman; C N Mallinson; G R Greenberg; S R Bloom
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

6.  Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin.

Authors:  D H Stern; J H Walsh
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

7.  Importance of bile in regulation of intraluminal proteolytic enzyme activities in the rat.

Authors:  G M Green; E S Nasset
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

8.  Effects of duodenal perfusion with sodium taurocholate on biliary and pancreatic secretion in man.

Authors:  O G Björnsson; P N Maton; D R Fletcher; V S Chadwick
Journal:  Eur J Clin Invest       Date:  1982-04       Impact factor: 4.686

9.  Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.

Authors:  G Adler; M Reinshagen; I Koop; B Göke; A Schafmayer; L C Rovati; R Arnold
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

10.  Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats.

Authors:  U R Fölsch; P Cantor; H M Wilms; A Schafmayer; H D Becker; W Creutzfeldt
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

View more
  5 in total

1.  Intraduodenal conjugated bile salts exert negative feedback control on gall bladder emptying in the fasting state without affecting cholecystokinin release or antroduodenal motility.

Authors:  N A M van Ooteghem; A Moschetta; J F Rehfeld; M Samsom; K J van Erpecum; G P van Berge-Henegouwen
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.

Authors:  I Koop; M Schindler; A Bosshammer; J Scheibner; E Stange; H Koop
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

3.  Role of endogenous bile on basal and postprandial CCK release in humans.

Authors:  M Koide; Y Okabayashi; M Otsuki
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

4.  Effect of predigested fat on intestinal stimulation of plasma cholecystokinin and gall bladder motility in coeliac disease.

Authors:  W P Hopman; G Rosenbusch; M P Hectors; J B Jansen
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 5.  Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.

Authors:  Morten Hansen; David P Sonne; Filip K Knop
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.